Labor Augsburg MVZ GmbH

Form 483 issued May 9, 2025 · Augsburg, Germany

Inspection
May 5 – May 9, 2025
Observations
2
Pages
2
FEI number
3036040213

In short: On May 9, 2025, FDA issued a Form 483 with 2 observations to Labor Augsburg MVZ GmbH in Augsburg, Germany (FEI 3036040213) after an inspection that ran May 5 – May 9, 2025. The investigator was Melkamu Getie-Kebtie. Most observations concern clinical (BIMO).

At a glance

2 of 2 observations on this 483 concern clinical (bimo).

Clinical (BIMO)2

What FDA observed

Preview: the opening words of each observation
  1. 01

    The fimi did not adhere to their established acceptance criterion for individual quality control samples in…

  2. 02

    The film did not retain the electronic source data (i.e., Cobas 6000 instrument generated readings [electrochemiluminescence…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Labor Augsburg MVZ GmbH?

FDA listed 2 observations on this Form 483, mostly about clinical (BIMO). The opening words of each observation are shown on this page.

Who inspected Labor Augsburg MVZ GmbH?

Melkamu Getie-Kebtie is named on this Form 483, for the inspection of May 5 – May 9, 2025. Each investigator has a profile showing what they cite most.

When was Labor Augsburg MVZ GmbH inspected by FDA?

The inspection ran May 5 – May 9, 2025, and the Form 483 is dated May 9, 2025.

How do I get the full Form 483 for Labor Augsburg MVZ GmbH?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free